Global In situ Hybridization Market

Dec 2018| VMR441A| Verified Market Research

Report Highlights

The global In situ Hybridization Market was valued at USD 556.87 million in 2016 and is projected to reach USD 921.82 million by 2025, growing at a CAGR of 5.76% from 2017 to 2025.

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ).

Market Dynamics:
1. Market Drivers
1.1 Increasing prevalence of cancer disease
1.2 Increasing diagnosis of cancer disease
1.3 Advancement in therapeutics technology
1.4 Rising government initiatives
1.5 Increasing demand of accurate prognostic tools
1.6 Increasing healthcare expenditure

2. Market Restraints
2.1 High Cost of Advanced Instruments
2.2 Lack of Professionals

Market Segmentation:
1. Global In situ Hybridization Market, by End User:
1.1 Molecular Diagnostic Laboratories
1.2 Pharmaceutical & Biotechnology Companies
1.3 Contract Research Organizations (CROS)
1.4 Academic & Research Institutions

2. Global In situ Hybridization Market, by Application:
2.1 Cancer Diagnosis
2.2 Immunology
2.3 Neuroscience
2.4 Cytology
2.5 Infectious Diseases

3. Global In situ Hybridization Market, by Technique:
3.1 Fluorescence In Situ Hybridization Market (FISH)
3.1.1 DNA-FISH
3.1.2 RNA-FISH
3.2 Chromogenic In Situ Hybridization Market (CISH)

4. Global In situ Hybridization Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. ABBott Laboratories, Inc.
2. F.Hoffmann-La Roche Ltd.
3. Thermofisher Scientific, Inc.
4. Merck KGaA
5. Agilent Technologies, Inc.
6. Perkin Elmer, Inc.
7. Danaher Corporation / Leica Biosystems Nussloch GmbH
8. Exiqon A/S
9. Biogenex Laboratories, Inc.
10. Advanced Cell Diagnostics, Inc
11. Bio Sb, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Research study on the In situ HybridizationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Verified Market Research
Price: $3950

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.